In the last few years, large Phase III trials showed improvements in survival and ... Hazard ratio; iv.: Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo; PSA ...
The FDA has approved the WATER IV PCa trial, which will compare the safety and efficacy ... Adding radium-223 to enzalutamide significantly improved survival outcomes in patients with metastatic ...
The first step is often a blood test for prostate-specific antigen (PSA). If ... Study Finds New Blood Test Predicts Prognosis ... Aggressive Prostate Cancer Subtype Oct. 4, 2024 — Researchers ...
Introduction of the serum PSA test to routine clinical practice in the mid-1980s changed the diagnosis ... prostate, which has led to a notable rise in the incidence of prostate cancer. [4 ...
This is also true in medicine and, in particular, in the field of prostate cancer. The concept of artificial intelligence ... surveillance with comprehensive follow-up at a median of 4.4 years. As ...
Two brothers have described being told they had cancer within weeks of each other. Keith Powell's prostate was removed just 12 weeks after his brother Alan, 66, had the same operation at the Royal ...
New Innovative Local Treatment for Osteolytic Bone ... among cancer patients. Researchers have now uncovered a 'genetic signature' of 177 genes shared ... Lung Cancer Test Predicts Survival ...
Stage 4 cervical cancer occurs when cancer has grown into nearby organs or has metastasized. The most common sites of metastasis are the lungs, bone, liver, and brain. In up to one in 10 cases, ...